Many studies into treating and managing post-stroke cognitive impairment are ongoing or are planned, to help address the lack of firm evidence base for clinical decision making in this complex patient population.
References:
1. ClinicalTrials.gov. Accessed Dec 2023.
2. Wilcock D, Jicha G, Blacker D, et al.; MarkVCID Consortium. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols. Alzheimers Dement 2021; 17 (4): 704–715.
3. Rost NS, Meschia JF, Gottesman R, et al.; DISCOVERY Investigators. Cognitive impairment and dementia after stroke: design and rationale for the DISCOVERY study. Stroke 2021; 52 (8): e499–e516.
4. Lo JW, Crawford JD, Desmond DW, et al.; Stroke and cognition (STROKOG) collaboration. Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups. Neurology 2019; 93 (24): e2257–e2271.